Health Condition 1: J410- Simple chronic bronchitis
Conditions
Interventions
Intervention1: Decoction: The formulation consists of Hyssopus officinalis (Zoofa Khusk) 6 g, Trigonella foenum-graecum (Hulba) 6 g, Glycyrrhiza glabra (Asl-us-Soos) 6 g, Iris ensata (Irsa) 6 g, along
Sponsors
Department of Moalajat Ajmal Khan Tibbiya College Aligarh Muslim University
Eligibility
Inclusion criteria
Inclusion criteria: Patients in the age group 30-65 years. Patients of either sex. Patient presenting cough with expectoration of at least three months of two consecutive years. Patient with FEV1 greater than or equal to 80 percent predicted (GOLD 1) and FEV1 more than 50 percent and less than 80 percent predicted (GOLD 2) , FEV1/FVC ratio less than 70 percent of predicted value. Prediabetic and diabetics (HbA1c less than 7%) Patient of chronic bronchitis in a stable condition without any signs of acute exacerbation of disease Patient underwent atleast 2 weeks washout period before randomization Those who give written consent
Exclusion criteria
Exclusion criteria: Acute exacerbation of disease Bronchial Asthma Patient demonstrating any radiographic evidence of infiltrates or pulmonary patches on Chest Xray Cor Pulmonale and Congestive Heart Failure, Pregnant & lactating mothers Patient having uncontrolled hypertension (BP greater then or equal to 160 by 100 mm Hg) , CLD, CKD Patient on oxygen therapy Obese Patients (BMI more than 30 kg per m2) Patients who fail to give consent Patients who fail to follow up Mentally retarded persons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Statistically significant increase in FEV1 observed from baseline to the end of the studyTimepoint: Day 0 and Day 60 | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in score of total BCSS and Wheezing scale shows improvement in symptoms. Timepoint: 15th, 30th , 45th, 60th day | — |
Countries
India
Contacts
Public ContactAsra Sadique
Ajmal Khan Tibbiya College
Outcome results
None listed